Clinical Impact of Immune Microenvironment in Stage I Lung Adenocarcinoma: Tumor Interleukin-12 Receptor β2 (IL-12Rβ2), IL-7R, and Stromal FoxP3/CD3 Ratio Are Independent Predictors of Recurrence - Concepedia

Concepedia

Publication | Open Access

Clinical Impact of Immune Microenvironment in Stage I Lung Adenocarcinoma: Tumor Interleukin-12 Receptor β2 (IL-12Rβ2), IL-7R, and Stromal FoxP3/CD3 Ratio Are Independent Predictors of Recurrence

DOI Full Paper Access

221

Citations

27

References

2012

Year

Kei Suzuki, Kyuichi Kadota, Camelia S. Sima, Jun‐ichi Nitadori, Valerie W. Rusch, William D. Travis, Michel Sadelain, Prasad S. Adusumilli

Journal of Clinical Oncology

Abstract

Our investigation confirms the biologic and prognostic significance of the tumor immune microenvironment for patients with stage I lung ADC and provides support for its use to stratify clinical outcome and immunotherapeutic interventions.

References

	Year	Citations

Page 1